HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christian Otte Selected Research

Metyrapone

4/2007Effects of metyrapone on hypothalamic-pituitary-adrenal axis and sleep in women with post-traumatic stress disorder.
10/2006Mineralocorticoid receptor function in posttraumatic stress disorder after pretreatment with metyrapone.
7/2006Neuroendocrine regulation of sleep disturbances in PTSD.
8/2004Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings.
9/2003Delta sleep response to metyrapone in post-traumatic stress disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christian Otte Research Topics

Disease

26Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
10/2022 - 11/2002
14Major Depressive Disorder (Major Depressive Disorders)
01/2022 - 05/2011
11Borderline Personality Disorder (Personality Disorders, Borderline)
02/2021 - 11/2013
9Wounds and Injuries (Trauma)
01/2022 - 08/2006
8Coronary Disease (Coronary Heart Disease)
05/2012 - 08/2004
5Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016 - 01/2005
4Mental Disorders (Mental Disorder)
01/2022 - 05/2012
4Inflammation (Inflammations)
01/2018 - 06/2010
4Alcoholism (Alcohol Abuse)
08/2006 - 01/2005
3Cardiovascular Diseases (Cardiovascular Disease)
12/2020 - 05/2012
2Obesity
01/2022 - 12/2020
2Fatigue
01/2022 - 07/2011
2Treatment-Resistant Depressive Disorder
01/2021 - 01/2020
2Cognitive Dysfunction
01/2020 - 11/2009
2Addison Disease (Addison's Disease)
01/2016 - 05/2015
2Stroke (Strokes)
09/2015 - 11/2008
2Cushing Syndrome
05/2012 - 12/2011
2Atherosclerosis
02/2011 - 08/2009
2Heart Failure
06/2010 - 11/2008
1Endocrine System Diseases (Endocrine Diseases)
01/2022
1Genetic Risk Score
01/2022
1Gambling (Pathological Gambling)
01/2020
1Abdominal Obesity
01/2015
1Chronic Pain
04/2013
1Acute Pain
04/2013
1Pain (Aches)
04/2013
1Low Back Pain (Lumbago)
04/2013
1Multiple Sclerosis
10/2012
1Necrosis
07/2011
1Psychotic Disorders (Schizoaffective Disorder)
04/2009
1Crohn Disease (Crohn's Disease)
04/2009
1Transient Ischemic Attack
11/2008
1Myocardial Infarction
11/2008
1Chronic Disease (Chronic Diseases)
09/2007

Drug/Important Bio-Agent (IBA)

35Hydrocortisone (Cortisol)FDA LinkGeneric
10/2022 - 11/2002
9GlucocorticoidsIBA
10/2022 - 11/2002
9Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
01/2022 - 11/2002
7Adrenocorticotropic Hormone (ACTH)FDA Link
04/2007 - 03/2002
5Biological ProductsIBA
01/2022 - 07/2006
5Dexamethasone (Maxidex)FDA LinkGeneric
01/2018 - 08/2004
5MetyraponeFDA Link
04/2007 - 09/2003
4C-Reactive ProteinIBA
01/2022 - 06/2010
4Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2020 - 11/2009
4Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2018 - 11/2005
4CatecholaminesIBA
02/2015 - 11/2005
3N-Methylaspartate (NMDA)IBA
10/2022 - 12/2020
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2022 - 12/2020
3KetamineFDA LinkGeneric
01/2021 - 01/2019
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2020 - 05/2012
3Antidepressive Agents (Antidepressants)IBA
12/2020 - 10/2010
3SteroidsIBA
01/2020 - 01/2016
3FludrocortisoneIBA
01/2016 - 10/2006
3Acamprosate (Campral)FDA Link
08/2006 - 01/2005
2Testosterone (Sustanon)FDA Link
02/2021 - 01/2016
2EscitalopramFDA Link
12/2020 - 10/2010
2Hormones (Hormone)IBA
01/2020 - 03/2002
2EndocannabinoidsIBA
01/2018 - 09/2014
2Corticotropin-Releasing HormoneIBA
01/2018 - 11/2002
2Triglycerides (Triacylglycerol)IBA
01/2015 - 08/2009
2CholesterolIBA
01/2015 - 05/2005
2Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
10/2010 - 09/2007
2Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA
04/2007 - 07/2006
2Naltrexone (ReVia)FDA LinkGeneric
07/2006 - 01/2005
1Cycloserine (Seromycin)FDA Link
10/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2022
1Oxytocin (Pitocin)FDA LinkGeneric
01/2022
1Oxytocin Receptors (Oxytocin Receptor)IBA
01/2022
1Glutamic Acid (Glutamate)FDA Link
12/2020
1Simvastatin (Zocor)FDA LinkGeneric
12/2020
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
11/2020
1AldosteroneIBA
01/2020
1Dehydroepiandrosterone (DHEA)IBA
01/2020
1AmylasesFDA Link
10/2019
1Steroid Receptors (Steroid Receptor)IBA
01/2019
1Pharmaceutical PreparationsIBA
12/2018
1Yohimbine (Yocon)IBA
12/2018
1Clonidine (ST 155)FDA LinkGeneric
12/2018
1InterleukinsIBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1CannabinoidsIBA
01/2018
1anandamide (arachidonylethanolamide)IBA
01/2018
1Prazosin (Minipress)FDA LinkGeneric
01/2017
1Doxazosin (Cardura)FDA LinkGeneric
01/2017
1Neuroprotective AgentsIBA
09/2015
1Fluoxetine (Prozac)FDA LinkGeneric
09/2015
1MineralocorticoidsIBA
05/2015
1Glucose (Dextrose)FDA LinkGeneric
01/2015
1CortisoneFDA Link
01/2015
1Neuropeptide YIBA
09/2014
1InterferonsIBA
07/2011
1CytokinesIBA
07/2011
1MethoxyhydroxyphenylglycolIBA
06/2011
1Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2010
1HDL LipoproteinsIBA
08/2009
1Blood Glucose (Blood Sugar)IBA
08/2009
1Infliximab (Remicade)FDA Link
04/2009
1Serotonin (5 Hydroxytryptamine)IBA
04/2009

Therapy/Procedure

3Secondary Prevention
08/2006 - 01/2005
1Therapeutics
01/2022
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2016